These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 17513032
61. Re-evaluation of randomized controlled trials of lithium monotherapy. Severus WE, Kleindienst N, Greil W. Bipolar Disord; 2006 Oct; 8(5 Pt 1):519-20; author reply 521. PubMed ID: 17042892 [No Abstract] [Full Text] [Related]
70. Lithium in bipolar adolescents with secondary substance dependency. Rohde LA, Szobot C. J Am Acad Child Adolesc Psychiatry; 1999 Jan; 38(1):4. PubMed ID: 9893405 [No Abstract] [Full Text] [Related]
71. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes. Choi-Kain LW, Pope HG. Harv Rev Psychiatry; 2007 Jan; 15(4):181-6. PubMed ID: 17687712 [No Abstract] [Full Text] [Related]
72. Neuroleptic malignant syndrome in cycloserine-induced psychosis. Sawant NS, Kate NS, Bhatankar SS, Kulkarni PS. Indian J Pharmacol; 2015 Jan; 47(3):328-9. PubMed ID: 26069374 [Abstract] [Full Text] [Related]
73. Treatment of mixed mania with risperidone and mood stabilizers. Benabarre A, Vieta E, Colom F, Martínez A, Reinares M, Corbella B. Can J Psychiatry; 2001 Nov; 46(9):866-7. PubMed ID: 11761645 [No Abstract] [Full Text] [Related]
76. Risperidone as an adjunct to valproic acid. Waring EW, Dewan VK, Cohen D, Grewal R. Can J Psychiatry; 1999 Mar; 44(2):189. PubMed ID: 10097843 [No Abstract] [Full Text] [Related]
77. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): one-year follow-up of a single case. Porto FH, Leite MA, Fontenelle LF, Marrocos RP, Szczerback NF, de Freitas MR. J Neurol Sci; 2009 Feb 15; 277(1-2):172-3. PubMed ID: 19046589 [Abstract] [Full Text] [Related]